🔍

DMCC - DMCC Speciality

📊 NSE: DMCC 🏢 Chemicals 📅 Last Updated: 12/13/2025 21:37

📢 Recent Corporate Announcements

DMCC Seeks Shareholder Approval for MD Re-appointment and Board Changes

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 11 Feb 2026, 04:03 PM

DMCC Speciality Chemicals has initiated a postal ballot to seek shareholder approval for the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term effective April 1, 2026. The company is also proposing the appointment of Saloni Jhaveri as a Women Independent Director for a five-year term and a revision in the remuneration of Executive Director Kuldeep Kumar Tiwari. Additionally, resolutions include the alteration of the Memorandum of Association and adoption of new Articles of Association. The e-voting process concludes on March 15, 2026, with results expected by March 17, 2026.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029)
Appointment of Saloni Jhaveri as Women Independent Director for a 5-year term starting January 2026
Revision of remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations), effective April 1, 2026
Proposed updates to the Memorandum of Association (MoA) and Articles of Association (AoA)
E-voting period scheduled from February 13, 2026, to March 15, 2026

💡 Investors should support the resolutions to ensure leadership continuity, while keeping an eye on the specific details of the remuneration revision in the full explanatory statement.

DMCC Q3FY26 Revenue Up 28% YoY to ₹151 Cr; PAT Declines 22% on Margin Pressure

🔵 WATCH ⭐ 7/10

EARNINGS 📅 07 Feb 2026, 03:27 PM

DMCC reported a strong 27.81% YoY growth in revenue to ₹150.87 crore for Q3FY26, driven by the resumption of the Boron business and improved realisations. However, EBITDA margins contracted significantly by 543 bps to 9.87% as elevated sulphur costs and a higher revenue base impacted percentages. While quarterly PAT fell 21.64% YoY to ₹6.17 crore, the 9-month performance remains robust with 9MFY26 PAT up 30.68% at ₹19.67 crore. The company expects the Boron segment to contribute ₹125-150 crore in annual revenue moving forward.

Revenue from operations grew 27.81% YoY to ₹150.87 crore in Q3FY26.
EBITDA margins compressed by 543 bps YoY to 9.87% due to high raw material costs and pricing divergence.
Resumed Boron operations are projected to generate ₹125-150 crore in annual revenue.
9MFY26 PAT increased by 30.68% to ₹19.67 crore compared to ₹15.06 crore in 9MFY25.
Sustainability initiatives now contribute over 80% of the company's energy requirements through solar and waste heat recovery.

💡 Investors should monitor the stabilization of margins as the company navigates volatile sulphur prices and the full-scale ramp-up of the Boron business. The strong 9-month cumulative growth suggests underlying resilience despite the quarterly margin hit.

DMCC Re-appoints Bimal Goculdas as MD & CEO for 3 Years; Approves Q3 FY26 Results

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 06 Feb 2026, 03:35 PM

DMCC Speciality Chemicals has approved the re-appointment of Bimal Lalitsingh Goculdas as Managing Director and CEO for a three-year term starting April 2026. The board also approved an increase in remuneration for Executive Director Kuldeep Kumar Tiwari and proposed significant updates to the company's Memorandum and Articles of Association to align with the Companies Act 2013. While the Q3 FY26 financial results were approved, the specific P&L figures were not detailed in the provided cover letter, though the auditor's review report was clean. These changes aim to provide better operational flexibility and governance alignment for the company.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 1, 2026, to March 31, 2029.
Proposed increase in remuneration for Shri Kuldeep Kumar Tiwari, Executive Director (Operations), subject to postal ballot approval.
Comprehensive update of Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act 2013.
Approval of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025.
The board meeting commenced at 1:00 p.m. and concluded at 3:05 p.m. on February 6, 2026.

💡 Investors should view the leadership continuity as a sign of stability for the company's long-term strategy. Monitor the upcoming Postal Ballot results and the detailed Q3 financial performance once fully released to assess operational growth.

DMCC Approves Q3 Results, Re-appoints CEO, and Proposes MOA/AOA Amendments

🟡 NEUTRAL ⭐ 6/10

BOARD_MEETING 📅 06 Feb 2026, 03:32 PM

DMCC Speciality Chemicals has approved its unaudited financial results for Q3 FY26 and announced the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term starting April 2026. The board also proposed significant amendments to the Memorandum and Articles of Association (MOA/AOA) to align with the Companies Act 2013 and provide greater operational flexibility for future activities. Additionally, a remuneration increase for the Executive Director of Operations was approved, subject to shareholder consent. These moves indicate a focus on leadership continuity and regulatory compliance.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 2026 to March 2029.
Proposed amendments to MOA Object and Liability clauses to align with Companies Act 2013 and enable future business flexibility.
Approval of remuneration increase for Kuldeep Kumar Tiwari, Executive Director (Operations), pending shareholder approval.
Consolidated results include subsidiary DMCC (Europe) GMBH, which contributed a nominal Rs 3.35 lacs to Q3 revenue.
Shareholder approval for management and regulatory changes to be sought via Postal Ballot.

💡 Investors should monitor the upcoming Postal Ballot notice for specific details on the expanded 'Object Clause' to identify potential new business segments. Leadership continuity is a positive sign for management stability.

DMCC Speciality Chemicals Approves Q3 FY26 Results and Re-appoints Bimal Goculdas as MD & CEO

🟡 NEUTRAL ⭐ 6/10

BOARD_MEETING 📅 06 Feb 2026, 03:21 PM

DMCC Speciality Chemicals has approved its unaudited financial results for the quarter ended December 31, 2025, alongside key leadership decisions. The board confirmed the re-appointment of Bimal Lalitsingh Goculdas as MD and CEO for a three-year term effective April 2026, ensuring management continuity. Additionally, the company is seeking shareholder approval to amend its Memorandum of Association (MOA) to provide greater operational flexibility for future business activities. While the main entity's specific profit figures were not detailed in the text, its European subsidiary reported a marginal profit of ₹0.86 lacs for the quarter.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029).
Proposed increase in remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations).
Amendment of MOA 'Main Objects' clause to allow for future business expansion and flexibility.
Adoption of new Articles of Association (AOA) to align with the Companies Act, 2013.
Subsidiary DMCC (Europe) GMBH reported a net profit of ₹0.86 lacs for the quarter ended Dec 31, 2025.

💡 Investors should review the full financial statements once published to assess core profitability trends. The management continuity is a positive sign, but the proposed changes to the MOA objects clause should be monitored for signs of diversification into new business segments.

DMCC Updates Authorized KMPs for Materiality Disclosures Under SEBI Regulations

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 10 Jan 2026, 02:23 PM

DMCC Speciality Chemicals Limited has updated its list of Key Managerial Personnel (KMP) authorized to determine the materiality of events and information for stock exchange disclosures. The Board of Directors approved this list during their meeting on January 10, 2026, in compliance with SEBI (LODR) Regulations. The authorized team includes the Managing Director & CEO, Sr. Executive Vice-President, and the CFO. Additionally, a new Company Secretary and Compliance Officer will join the authorized group effective January 27, 2026.

Board authorized 4 Key Managerial Personnel for materiality determinations on January 10, 2026
Shri Bimal Lalitsingh Goculdas (MD & CEO) and Shri Sunil Kumar Goyal (CFO) remain key contacts
Ms. Pallavi Pednekar appointed as Company Secretary & Compliance Officer effective January 27, 2026
Disclosure made under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements)

💡 This is a routine administrative update regarding corporate governance and compliance. No immediate action is required as it does not impact the company's financial performance.

DMCC Appoints Saloni Jhaveri as Independent Director and Pallavi Pednekar as Company Secretary

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Jan 2026, 01:55 PM

DMCC Speciality Chemicals has announced two key leadership appointments following its board meeting on January 10, 2026. Ms. Saloni Jhaveri, who brings over 20 years of experience in M&A and private equity, has been appointed as an Independent Director for a five-year term. Additionally, Ms. Pallavi Pednekar, with 12 years of secretarial experience, will take over as Company Secretary and Compliance Officer starting January 27, 2026. These appointments are aimed at strengthening the company's corporate governance and strategic oversight.

Ms. Saloni Jhaveri appointed as Non-Executive Independent Director for a 5-year term until January 9, 2031
Ms. Pallavi Pednekar appointed as Company Secretary and Compliance Officer effective January 27, 2026
Ms. Jhaveri has over 20 years of experience in M&A and currently heads Investor Relations at NIIF
Ms. Pednekar brings 12 years of experience in legal and secretarial functions from firms like NGL Fine-Chem
The appointments were approved by the Board of Directors in a meeting held on January 10, 2026

💡 These are routine leadership changes focused on corporate governance and compliance. Investors should view this as a neutral development with no immediate impact on stock fundamentals.

DMCC Appoints Saloni Jhaveri as Independent Director and New Company Secretary

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Jan 2026, 01:49 PM

DMCC Speciality Chemicals Limited has announced key leadership appointments following its board meeting on January 10, 2026. Ms. Saloni Jhaveri, an expert with over 20 years of experience in private equity and M&A, has been appointed as an Independent Director for a five-year term. Furthermore, Ms. Pallavi Pednekar, who possesses 12 years of experience in secretarial and legal functions, will take over as Company Secretary and Compliance Officer starting January 27, 2026. These appointments are intended to bolster the company's corporate governance and strategic advisory capabilities.

Ms. Saloni Jhaveri appointed as Additional Independent Director for a 5-year term ending January 9, 2031.
Ms. Pallavi Pednekar appointed as Company Secretary and Compliance Officer effective January 27, 2026.
New Independent Director brings over 20 years of experience in M&A, corporate finance, and fundraising.
New Company Secretary has 12 years of experience, previously serving at NGL Fine-Chem Limited.

💡 These are routine management and governance updates. Investors should note the addition of M&A expertise to the board, which could be beneficial for future strategic initiatives.

DMCC Appoints Saloni Jhaveri as Independent Director and New Company Secretary

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Jan 2026, 01:47 PM

DMCC Speciality Chemicals Limited has announced the appointment of Ms. Saloni Jhaveri as an Additional Non-Executive Independent Director for a five-year term starting January 10, 2026. Ms. Jhaveri brings over 20 years of experience in private equity and M&A, currently heading Investor Relations at NIIF. Furthermore, the company has appointed Ms. Pallavi Pednekar as the Company Secretary and Compliance Officer, effective January 27, 2026. These appointments are intended to strengthen the board's expertise and ensure robust regulatory compliance.

Ms. Saloni Jhaveri appointed as Independent Director for a 5-year term until January 9, 2031
Ms. Pallavi Pednekar appointed as Company Secretary and Compliance Officer effective January 27, 2026
Ms. Jhaveri has over 20 years of experience in M&A and corporate finance across India and the US
Ms. Pednekar brings 12 years of experience in secretarial and legal functions from firms like NGL Fine-Chem

💡 These are routine leadership appointments and do not necessitate any immediate change in investment stance. Investors should view the addition of an experienced M&A professional to the board as a positive step for corporate governance.

DMCC Speciality Chemicals Submits SEBI Regulation 74(5) Compliance Certificate for Q3 FY2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 07 Jan 2026, 11:21 AM

DMCC Speciality Chemicals Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by MUFG Intime India Private Limited, confirms that all dematerialization requests for the quarter ended December 31, 2025, were processed within prescribed timelines. It further verifies that security certificates were mutilated, cancelled, and the depository names were updated in the register of members. This filing is a standard procedural requirement to ensure the accuracy of electronic shareholding records.

Compliance certificate submitted for the quarter ended December 31, 2025.
Confirmation that dematerialization requests were processed and listed on stock exchanges where earlier securities are listed.
Verification that physical certificates were mutilated and cancelled after due verification by the depository participant.
The Registrar and Share Transfer Agent (RTA) involved is MUFG Intime India Private Limited (formerly Link Intime).

💡 This is a routine regulatory filing confirming administrative compliance; no action is required from investors as it does not impact company fundamentals.

DMCC Trading Window Closure: January 1, 2026

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 15 Dec 2025, 03:23 PM

DMCC Speciality Chemicals Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed from January 1, 2026, until 48 hours after the board meeting where the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, will be considered. Shareholders should note this restriction on trading company shares during this period.

Trading window closes from January 1, 2026
Closure is until 48 hours after the board meeting for Q3 results
Results for quarter and nine months ended December 31, 2025 will be considered

💡 Investors who are designated persons or their relatives should refrain from trading in DMCC shares during the trading window closure period. Monitor for the announcement of the board meeting date for Q3 results.

DMCC: Sonal Naik Resigns as Company Secretary & Compliance Officer

🟡 NEUTRAL ⭐ 5/10

MANAGEMENT 📅 03 Dec 2025, 04:35 PM

DMCC Speciality Chemicals Limited announced the resignation of Ms. Sonal Naik from the position of Company Secretary & Compliance Officer, effective December 16, 2025. Ms. Naik is leaving to explore opportunities outside the organization. Consequently, she will also cease to be a Key Managerial Personnel as per Section 203 of the Companies Act, 2013. The company is in the process of finding a suitable replacement.

Ms. Sonal Naik resigned as Company Secretary & Compliance Officer.
Resignation effective from close of business hours on December 16, 2025.
Ms. Naik will cease to be Key Managerial Personnel on December 16, 2025.
ICSI Membership No. of Sonal Naik is ACS 43179.

💡 Investors should monitor the appointment of the new Company Secretary & Compliance Officer. This change is part of normal business operations.

DMCC: Supreme Court rules in favor regarding 52-acre land

🟢 POSITIVE ⭐ 6/10

LEGAL 📅 01 Dec 2025, 05:12 PM

DMCC Speciality Chemicals has announced that the Supreme Court of India ruled in its favor regarding a civil appeal. The appeal concerned a 52-acre piece of land in Nalimbi, near Ambernath, Taluka, Kalyan, which the government of Maharashtra had previously designated as Forest Land under The Maharashtra Private Forest (Acquisition) Act, 1975. The Supreme Court's decision quashes the previous orders and declarations, directing corrections in revenue records. DMCC will now take necessary steps as advised, potentially unlocking value from this land.

Company owns 52 acres of land at village Nalimbi
Land was acquired under The Maharashtra Private Forest (Acquisition) Act, 1975
Civil appeal was filed before Supreme Court of India (SCI)
Supreme Court quashed orders treating land as 'Forest Land'

💡 Investors should monitor DMCC's actions regarding the 52-acre land and any potential impact on the company's financials. This ruling could positively affect the company's asset value.

View All DMCC Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Revenue grew 26% YoY in 9MFY25 to INR 306 Cr. In FY23, bulk chemicals grew 18% and contributed 47-48% of total sales (INR 184.6 Cr), while specialty chemicals contributed the remaining 52-53%.

Geographic Revenue Split

The company serves both domestic and overseas markets across various geographies, though the specific percentage split between regions is not disclosed in available documents.

Profitability Margins

PAT margins were 3.51% in FY24 (INR 11.59 Cr), up from 1.80% in FY23 (INR 6.93 Cr), but down from 6.55% in FY22 (INR 21.36 Cr). Operating margins have been volatile, ranging from 8.8% to 23.6% over the last five years.

EBITDA Margin

EBITDA margin was 13.69% in 9MFY25, an improvement from 10.60% in Q1FY25 and 8.8% in FY23. The company expects to maintain operating margins between 13% and 14% over the medium term.

Capital Expenditure

The company has no major debt-funded capex plans over the medium term, as recent 'enhanced capacities' are already expected to support business profile growth.

Credit Rating & Borrowing

CRISIL Ratings maintains a 'Stable' outlook. Bank loan facilities were recently enhanced from INR 105 Cr to INR 125 Cr, with bank limit utilization low at approximately 39% to 49.38% in 2024.

⚙️ Operational Drivers

Raw Materials

Major raw materials include sulfur, benzene, ethanol, and boron, which collectively account for 60-65% of total sales costs.

Capacity Expansion

Current capacity is described as 'enhanced' following previous expansions; no specific MTPA figures or new planned expansion timelines are provided for the medium term.

Raw Material Costs

Raw material costs represent 60-65% of revenue. Profitability is highly susceptible to price fluctuations in these inputs, with a limited ability to pass on costs in the bulk chemical segment (48% of sales).

Manufacturing Efficiency

Manufacturing efficiency is supported by three decades of promoter experience and plants located in Roha (Maharashtra) and Dahej (Gujarat).

📈 Strategic Growth

Expected Growth Rate

21-24%

Growth Strategy

Growth will be achieved by utilizing recently enhanced capacities, focusing on higher-margin specialty chemicals (8 key products), and leveraging established market positions in sulfur and ethanol chemistry to reach an estimated FY25 revenue of INR 400-410 Cr.

Products & Services

Sulphuric acid, specialty and commodity chemicals based on sulphur, ethanol, and boron chemistries.

Brand Portfolio

Ship brand (formerly used for phosphate fertilizers).

New Products/Services

The company recently achieved higher realizations from Boron products, contributing to a 13.69% EBITDA in 9MFY25.

Market Expansion

The company is expanding its presence in domestic and overseas markets through its established relations with reputed clients across geographies.

Strategic Alliances

Borax Morarji Ltd was amalgamated with DMCC effective April 01, 2016, to consolidate the chemical business.

🌍 External Factors

Industry Trends

The industry is shifting toward specialty chemicals to stabilize margins; DMCC is positioning itself with 8 specialty products to counter the volatility of its 4 bulk chemical products, aiming for a 13-14% operating margin.

Competitive Landscape

High competition exists in the commodity/bulk chemical segments, while specialty segments offer more protected margins.

Competitive Moat

The moat is based on a 100+ year history (incorporated 1919), status as a pioneer in sulphuric acid, and a diversified portfolio that allays sectoral concentration risks.